
    
      The aim is to measure the acute effects of tolvaptan on:

        1. Renal hemodynamics (RPF, GFR, filtration fraction ((FF)) and renovascular resistance
           ((RVR))

        2. Blood pressure (central blood pressure ((cBP)) and brachial blood pressure bBP)

        3. Several vasoactive hormones (plasma renin ((PRC)), plasma angiotensin II ((p-Ang-II)),
           plasma aldosterone ((p-Aldo)), plasma vasopressin ((p-AVP))

      in patients with ADPKD.
    
  